Kazuhiko Sueyoshi

Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan.

Upsher-Smith Laboratories, Inc. manufactures generic pharmaceuticals. It serves the pharmacists, physicians, and patients. The firm offers manufacturing, distribution, sales, and marketing services. The company was founded by Frederick Alfred Upsher Smith in 1919 and is headquartered in Maple Grove, MN.

Part of SAWAI GROUP HOLDINGS Co., Ltd., Medisa Shinyaku, Inc. is a pharmaceutical company based in Osaka, Japan. The company's description is in Japanese, but it appears to be a subsidiary of Sawai Pharmaceutical Co., Ltd. and is involved in the manufacture and sale of pharmaceuticals. The private company has been updating its corporate information and has made several announcements regarding its business activities.